Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $310.00. The ...

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Biogen (BIIB – Research Report), with a price target ...

The firm reiterated its Overweight rating for U.S. Bancorp (BVMF:USBC34), indicating a positive outlook despite the current discounted valuation. Analysts believe that the potential for improving ...

Fintel reports that on January 14, 2025, Piper Sandler downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) ...

Navigate stock market volatility and long-term investments by understanding the impact of inflation, bond rates, and Federal ...

Piper Sandler estimates that AI/HPC data center contracts could potentially triple miner EBITDA at certain sites. The note ...

UnitedHealth (UNH) stock and CVS Health (CVS) stock were named top picks at Piper Sandler on a potential hike in Medicare payments next year. Read more here.

Multiple fertilizer makers are climbing today after investment bank Piper Sandler upgraded several names in the space today.

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a managing director to the healthcare investment banking team. Kerins will ...

Despite recent share appreciation, Piper Sandler believes there is still significant upside for Kenvue. “Though shares have ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...